M. S. Hirsch

Harvard University — United States

Immunology and Microbiology · Life Sciences

29h-index4.2kcitations53works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

HIV Research and Treatment(13), Herpesvirus Infections and Treatments(12), Cytomegalovirus and herpesvirus research(10), HIV/AIDS drug development and treatment(8), Virus-based gene therapy research(8)

Publications53 total

T Cell-Mediated Autoimmune Phenomena Associated with the Pathogenesis of Lymphomas Induced by Moloney Murine Leukemia Virus1
Proceedings of the International Symposium on Comparative Leukemia Research·2015
Autoaggressive Reactions and Leukemia Virus Infections : Interrelated Events in Their Pathogenesis
Proceedings of the International Symposium on Comparative Leukemia Research·2015
Reply to Korch
The Journal of Infectious Diseases·2014Open Access
Editorial Comment Regarding H5N1 Influenza Article in This Issue
The Journal of Infectious Diseases·2012· 5 citedOpen Access
Progressive Reversion of Human Immunodeficiency Virus Type 1 Resistance Mutations In Vivo after Transmission of a Multiply Drug-Resistant Virus
Clinical Infectious Diseases·2003· 126 citedOpen Access
Susceptibility of human cytomegalovirus to two-drug combinations in vitro.
PubMed·1996· 23 cited
Lamivudine or Stavudine in Two- and Three-Drug Combinations against Human Immunodeficiency Virus Type 1 Replication In Vitro
The Journal of Infectious Diseases·1996· 100 cited
Naphthalene sulfonate polymers with CD4-blocking and anti-human immunodeficiency virus type 1 activities
Antimicrobial Agents and Chemotherapy·1996· 147 citedOpen Access
Inhibition Of Human Immunodeficiency Virus Type 1 Replication In Cytokinestimulated Monocytesjmacrophages By Combination Therapy
The Journal of Infectious Diseases·1994· 23 cited
Dual Infection of Retina with Human Immunodeficiency Virus Type 1 and Cytomegalovirus
Retina·1991· 4 cited
Three-Drug Synergistic Inhibition of HIV-l Replication In Vitro by Zidovudine, Recombinant Soluble CD4, and Recombinant Interferon-alpha A
The Journal of Infectious Diseases·1990· 72 cited
Synergistic Interaction of 2',3'-Dideoxycytidine and Recombinant Interferon- -A on Replication of Human Immunodeficiency Virus Type 1
The Journal of Infectious Diseases·1988· 46 cited
A Serological Investigation of BK Virus and JC Virus Infections in Recipients of Renal Allografts
The Journal of Infectious Diseases·1988· 151 cited
Circulating Interferon Gamma in AIDS Patients Treated with Interleukin-2
New England Journal of Medicine·1988· 15 cited
Bidirectional Interactions Between Human Immunodeficiency Virus Type 1 and Cytomegalovirus
The Journal of Infectious Diseases·1988· 272 cited
Antibodies to Human Immunodeficiency Virus in Cervical Secretions from Women at Risk for AIDS
The Journal of Infectious Diseases·1987· 60 citedOpen Access
Treatment of human immunodeficiency virus infections
Antimicrobial Agents and Chemotherapy·1987· 61 citedOpen Access
Isolation of HTLV-III from CSF and neural tissues of patients with AIDS-related neurological syndromes
Annales de l Institut Pasteur Virologie·1987· 11 cited
Prospects for the Prevention and Therapy of Infections with the Human Immunodeficiency Virus
Clinical Infectious Diseases·1986· 20 cited
Synergistic inhibition of human T-cell lymphotropic virus type III replication in vitro by phosphonoformate and recombinant alpha-A interferon
Antimicrobial Agents and Chemotherapy·1986· 64 citedOpen Access
page 1 of 3Next →

Frequent Co-authors

Paul H. Black(6), Walter P. Carney(5), Ting‐Chao Chou(5), Joan C. Kaplan(5), R. T. Schooley(5), R H Rubin(4), Debra P. Merrill(4), Robert T. Schooley(4), Kevan L. Hartshorn(3), A. C. Allison(3), E G Sandstrom(3), F. A. Murphy(3), V. R. Iacoviello(3), Timothy Paradis(3), JoanC. Kaplan(2), RobertT. Schooley(2), B. Zisman(2), Paul R. Skolnik(2), Barry Kosloff(2), D E Craven(2)